AETERNUM HEALTH, INC.
AETNdata completeness 75%17 fiscal years on fileData notes: no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'pretaxIncome'
| Figure | FY 2023 | FY 2023 | FY 2024 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $22,2811 | $20,1092 | $19,6101 | $65,1213 | $203,6553 |
| Net income | −$315,5244 | −$632,9485 | −$661,9654 | −$450,3186 | −$337,0946 |
| Operating cash flow | −$303,3327 | −$267,0348 | −$341,6077 | −$154,0469 | −$2,9589 |
| Capital expenditure | — | — | — | — | — |
| Free cash flow (derived) | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $010 | $011 | $010 | $012 | $012 |
| Diluted shares | 47.1M | 42.5M | 48.1M | 48.5M | 49.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$0.41 of net worth that earned you −$0.07 last year.
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Share count is up 4% over 5 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2023-02-28 · accession 0001493152-24-023724 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K/A · period ending 2023-12-31 · accession 0001641172-25-026345 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-014008 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-02-28 · accession 0001493152-24-023724 (NetIncomeLoss)
- 10-K/A · period ending 2023-12-31 · accession 0001641172-25-026345 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-014008 (NetIncomeLoss)
- 10-K · period ending 2023-02-28 · accession 0001493152-24-023724 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2023-12-31 · accession 0001641172-25-026345 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-014008 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-02-28 · accession 0001493152-24-023724 (CashAndCashEquivalentsAtCarryingValue)
- 10-K/A · period ending 2023-12-31 · accession 0001641172-25-026345 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-014008 (CashAndCashEquivalentsAtCarryingValue)